Severin Rodler

Dr. Severin Rodler


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 July 2024 in Die Urologie
Verified
Journal Article
Closed access
PDF file
KKKarl-Friedrich Kowalewski
Karl-Friedrich Kowalewski
SRSeverin Rodler
Severin Rodler

27 November 2025 in Current Oncology
Verified
Journal Article
Open access
PDF file
LBLeonhard Buck
Leonhard Buck
JKJakob Kohler
Jakob Kohler
JRJulian Risch
Julian Risch
RIReha-Baris Incesu
Reha-Baris Incesu
KHKonrad Hügelmann
Konrad Hügelmann
SRSeverin Rodler
Severin Rodler
Background: Multimodal artificial intelligence (MMAI) is transforming urological oncology by enabling the seamless integration of diverse data sources, including imaging, clinical records and robotic telemetry to facilitate patient-specific decision-making. Methods: This narrative review summarizes the current developments, applications, opportunities and risks of multimodal AI systems throughout the entire perioperative process in uro-oncologic surgery. Results: MMAI demonstrates quantifiable benefits across the entire perioperative pathway. Preoperatively, it improves diagnostics and surgical planning via multimodal data fusion. Intraoperatively, AI-assisted systems provide real-time context-based decision support, risk prediction and skill assessment within the operating theater. Postoperatively, MMAI facilitates automated documentation, early complication detection and personalized follow-up. Generative AI further revolutionizes surgical training through adaptive feedback and simulations. However, critical limitations must be addressed, including data bias, the barrier of closed robotic platforms, insufficient model validation, data security issues, hallucinations and ethical concerns regarding liability and transparency. Conclusions: MMAI significantly enhances the precision, efficiency and patient-centeredness of uro-oncological care. To ensure safe and widespread implementation, resolving the technical and regulatory barriers to real-time integration into robotic platforms is paramount. This must be coupled with standardized quality controls, transparent decision-making processes and responsible integration that fully preserves physician autonomy.

1 July 2025 in Cancers
Verified
Journal Article
Open access
PDF file
SRSeverin Rodler
Severin Rodler
SLStephan T. Ledderose
Stephan T. Ledderose
RWRaphaela Waidelich
Raphaela Waidelich
JKJakob Kohler
Jakob Kohler
ASAndrea Sendelhofert
Andrea Sendelhofert
LELennert Eismann
Lennert Eismann
Immune checkpoint inhibition is a cornerstone of bladder cancer therapy, but its efficacy in non-urothelial subtypes of bladder cancer is limited, and the prognosis remains poor. Therefore, we investigated the potential of the immune checkpoint molecules TIM-3, TIGIT, and LAG-3 in squamous-cell carcinoma (SCC) and adenocarcinoma (ADENO) of the urinary bladder. Tumor-infiltrating lymphocytes (TILs) showed a high expression of TIM-3 and TIGIT in both SCC and ADENO, while LAG-3-positive TILs were absent in ADENO and present in 46% of SCC. Quantitative analysis revealed age-independent expression of TIM-3 in SCC (r = −0.001, p = 0.997) and ADENO (r = 0.135, p = 0.549), with increasing age correlating with higher expression of TIGIT (r = 0.157, p = 0.242) and LAG-3 (0.106, p = 0.436) in the SCC cohort and of TIGIT (r = 0.276, p = 0.214) in the ADENO cohort. Male patients showed increased TIGIT scores in ADENO (p < 0.01). Of note, a high infiltration of TIM-3-TILs (p = 0.048) correlated with worse progression-free survival in SCC. These results highlight the differential expression of co-inhibitory receptors in non-urothelial bladder cancer subtypes and provide preclinical evidence for new therapeutic targets. Biomarker testing prior to clinical trials is essential for identifying the most suitable patients for targeted immunotherapy.

24 June 2025 in Die Urologie
Verified
Journal Article
Closed access
SRSeverin Rodler
Severin Rodler
KHKonrad Hügelmann
Konrad Hügelmann
HKHans Christoph von Knobloch
Hans Christoph von Knobloch
MWMarie-Luise Weiss
Marie-Luise Weiss
LBLeonhard Buck
Leonhard Buck
PNPhilipp Nuhn
Philipp Nuhn

3 June 2026 in Die Urologie
Verified
Journal Article
Closed access
SRSeverin Rodler
Severin Rodler
HBHendrik Borgmann
Hendrik Borgmann

23 February 2026 in Journal of Robotic Surgery
Verified
Journal Article
Open access
PDF file
IAIbrahim Alkatout
Ibrahim Alkatout
AKAlmut Kalz
Almut Kalz
Robert BergholzRobert Bergholz
Robert Bergholz
KBKai Bachmann
Kai Bachmann
JBJan Henrik Beckmann
Jan Henrik Beckmann
TBThomas Becker
Thomas Becker
We are looking back on over 10 years of successful work and numerous milestones in the interdisciplinary center of minimally invasive surgery, robotic surgery in particular. The success is largely owing to the spirit of sharing and collaborating — rather than competing — across the surgical disciplines. The collaboration became particularly fruitful by including the Kiel Center of Clinical Anatomy of Kiel University where many surgical approaches and techniques have been developed or refined on body donors. Apart from the traditional and renowned “Kiel school” for training in gynecological endoscopy built on the heritage of Kurt Semm; a training center (Kurt-Semm-Academy) for robot-assisted surgery was founded in 2020. The Kurt-Semm-Center has always followed the credo of establishing the best surgical technology for the best possible patient treatment. The ambitious claim to offer not only state-of-the-art surgery, but also to advance it further through studies and research, both experimental and clinical. This is evidenced by the enormous output of innovative research and publication activity, some of which is presented in this article. The key to success has been co-working across the disciplines, with continuing tenacity and dedication to state-of-the-art minimally invasive surgery. We believe that many hospitals could profit from an interdisciplinary spirit, having realized that individual department-specific interests are eventually better met when people learn from each other and work as a team. This article is dedicated to the spiritus rector of the Kurt-Semm-Zentrum, Prof. Dr. med. Klaus-Peter Jünemann.